Galectin Therapeutics Inc (GALT)
3.37
+0.33
(+10.86%)
USD |
NASDAQ |
Apr 23, 16:00
3.37
0.00 (0.00%)
After-Hours: 20:00
Galectin Therapeutics Free Cash Flow (Quarterly): -4.702M for Dec. 31, 2023
Free Cash Flow (Quarterly) Chart
Historical Free Cash Flow (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -4.702M |
| September 30, 2023 | -7.637M |
| June 30, 2023 | -9.833M |
| March 31, 2023 | -10.79M |
| December 31, 2022 | -7.239M |
| September 30, 2022 | -8.347M |
| June 30, 2022 | -7.428M |
| March 31, 2022 | -8.042M |
| December 31, 2021 | -6.951M |
| September 30, 2021 | -4.998M |
| June 30, 2021 | -5.977M |
| March 31, 2021 | -6.382M |
| December 31, 2020 | -5.414M |
| September 30, 2020 | -8.212M |
| June 30, 2020 | -2.604M |
| March 31, 2020 | -4.371M |
| December 31, 2019 | -3.759M |
| September 30, 2019 | -1.475M |
| June 30, 2019 | -2.33M |
| March 31, 2019 | -3.284M |
| December 31, 2018 | -2.007M |
| September 30, 2018 | -1.577M |
| June 30, 2018 | -3.079M |
| March 31, 2018 | -3.516M |
| December 31, 2017 | -3.904M |
| Date | Value |
|---|---|
| September 30, 2017 | -3.123M |
| June 30, 2017 | -5.002M |
| March 31, 2017 | -3.863M |
| December 31, 2016 | -4.865M |
| September 30, 2016 | -3.444M |
| June 30, 2016 | -4.61M |
| March 31, 2016 | -3.49M |
| December 31, 2015 | -4.601M |
| September 30, 2015 | -5.084M |
| June 30, 2015 | -2.987M |
| March 31, 2015 | -4.311M |
| December 31, 2014 | -3.113M |
| September 30, 2014 | -3.282M |
| June 30, 2014 | -2.412M |
| March 31, 2014 | -3.619M |
| December 31, 2013 | -1.646M |
| September 30, 2013 | -1.483M |
| June 30, 2013 | -1.932M |
| March 31, 2013 | -2.423M |
| December 31, 2012 | -1.754M |
| September 30, 2012 | -2.081M |
| June 30, 2012 | -2.184M |
| March 31, 2012 | -1.486M |
| December 31, 2011 | -1.542M |
| September 30, 2011 | -1.256M |
Free Cash Flow Definition
Free cash flow measures the amount of cash left over from a time period after all operational and working capital payments are made. Free cash flow is an important metric because it allows you to view the amount actual cash is available to the company. Free cash flow is also commonly used in valuation calculations like the discounted cash flow valuation model.
Free Cash Flow (Quarterly) Range, Past 5 Years
-10.79M
Minimum
Mar 2023
-1.475M
Maximum
Sep 2019
-6.131M
Average
-6.382M
Median
Mar 2021
Free Cash Flow (Quarterly) Benchmarks
| Madrigal Pharmaceuticals Inc | -80.97M |
| Viking Therapeutics Inc | -17.64M |
| 89bio Inc | -34.29M |
| Terns Pharmaceuticals Inc | -19.36M |
| Enanta Pharmaceuticals Inc | -25.78M |